Literature DB >> 20204459

Decreased pygopus 2 expression suppresses glioblastoma U251 cell growth.

Zhan-Xiang Wang1, Yu-Ying Chen, Bo-An Li, Guo-Wei Tan, Xi-Yao Liu, Shang-Hang Shen, Hong-Wei Zhu, Hai-Dong Wang.   

Abstract

Gliomas are common malignant tumors of the human neural system, and Wnt signaling activation is closely related to glioma malignancy. Human Pygopus 2 (Pygo2) was recently discovered to be a component of the Wnt signaling pathway, which is required for β-catenin/Tcf-dependent transcription. However, the role of Pygo2 in glioblastoma cell growth and survival remains uncertain. In the present study, Pygo2 expression was evaluated in 80 glioma tissue samples. Results demonstrated that tumor grade exhibited a positive correlation with overexpression of Pygo2. In addition, small hairpin RNA (shRNA) was used to specifically knockdown Pygo2 expression in human glioblastoma U251 cell lines. Results showed that inhibition of Pygo2 expression resulted in inhibited cell proliferation and invasiveness, as well as increased cell cycle arrest at the G(1) stage and decreased expression of the Wnt target gene cyclin D1. These results demonstrated that Pygo2 was highly expressed in glioma tissue and required for growth of glioblastoma cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20204459     DOI: 10.1007/s11060-010-0144-6

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  38 in total

Review 1.  Wnt signaling and cancer.

Authors:  P Polakis
Journal:  Genes Dev       Date:  2000-08-01       Impact factor: 11.361

2.  Wnt/wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear beta-catenin-TCF complex.

Authors:  Thomas Kramps; Oliver Peter; Erich Brunner; Denise Nellen; Barbara Froesch; Sandipan Chatterjee; Maximilien Murone; Stephanie Züllig; Konrad Basler
Journal:  Cell       Date:  2002-04-05       Impact factor: 41.582

Review 3.  The Hedgehog and Wnt signalling pathways in cancer.

Authors:  J Taipale; P A Beachy
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

Review 4.  Wnt, stem cells and cancer in the intestine.

Authors:  Daniel Pinto; Hans Clevers
Journal:  Biol Cell       Date:  2005-03       Impact factor: 4.458

5.  Requirement of Pygopus 2 in breast cancer.

Authors:  Phillip G P Andrews; Blue B Lake; Catherine Popadiuk; Kenneth R Kao
Journal:  Int J Oncol       Date:  2007-02       Impact factor: 5.650

Review 6.  The Wnt signaling pathway and its role in tumor development.

Authors:  B Lustig; J Behrens
Journal:  J Cancer Res Clin Oncol       Date:  2003-04-18       Impact factor: 4.553

7.  Identification of c-MYC as a target of the APC pathway.

Authors:  T C He; A B Sparks; C Rago; H Hermeking; L Zawel; L T da Costa; P J Morin; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1998-09-04       Impact factor: 47.728

Review 8.  Caught up in a Wnt storm: Wnt signaling in cancer.

Authors:  Rachel H Giles; Johan H van Es; Hans Clevers
Journal:  Biochim Biophys Acta       Date:  2003-06-05

9.  The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway.

Authors:  M Shtutman; J Zhurinsky; I Simcha; C Albanese; M D'Amico; R Pestell; A Ben-Ze'ev
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

10.  Pygopus, a nuclear PHD-finger protein required for Wingless signaling in Drosophila.

Authors:  David S Parker; Jemileh Jemison; Kenneth M Cadigan
Journal:  Development       Date:  2002-06       Impact factor: 6.868

View more
  14 in total

1.  Akt Phosphorylates Wnt Coactivator and Chromatin Effector Pygo2 at Serine 48 to Antagonize Its Ubiquitin/Proteasome-mediated Degradation.

Authors:  Qiuling Li; Yuewei Li; Bingnan Gu; Lei Fang; Pengbo Zhou; Shilai Bao; Lan Huang; Xing Dai
Journal:  J Biol Chem       Date:  2015-07-13       Impact factor: 5.157

2.  Downregulation of Pygopus 2 inhibits vascular mimicry in glioma U251 cells by suppressing the canonical Wnt signaling pathway.

Authors:  Haidong Wang; Jianhua Fu; Dianshuang Xu; Weiwei Xu; Shiyong Wang; Liu Zhang; Yongsheng Xiang
Journal:  Oncol Lett       Date:  2015-11-13       Impact factor: 2.967

3.  Pygo2 activates MDR1 expression and mediates chemoresistance in breast cancer via the Wnt/β-catenin pathway.

Authors:  Z-M Zhang; J-F Wu; Q-C Luo; Q-F Liu; Q-W Wu; G-D Ye; H-Q She; B-A Li
Journal:  Oncogene       Date:  2016-02-15       Impact factor: 9.867

4.  Pygo2 siRNA Inhibit the Growth and Increase Apoptosis of U251 Cell by Suppressing Histone H3K4 Trimethylation.

Authors:  Mingcong Li; Linlin Chao; Jian Wu; Hao Xu; Shanghan Shen; Sifang Chen; Xin Gao; Ning Yu; Zhanxiang Wang
Journal:  J Mol Neurosci       Date:  2015-04-14       Impact factor: 3.444

5.  Allosteric remodelling of the histone H3 binding pocket in the Pygo2 PHD finger triggered by its binding to the B9L/BCL9 co-factor.

Authors:  Thomas C R Miller; Trevor J Rutherford; Christopher M Johnson; Marc Fiedler; Mariann Bienz
Journal:  J Mol Biol       Date:  2010-07-14       Impact factor: 5.469

6.  β-Catenin Signalling in Glioblastoma Multiforme and Glioma-Initiating Cells.

Authors:  Mireia Nager; Deepshikha Bhardwaj; Carles Cantí; Loreta Medina; Pere Nogués; Judit Herreros
Journal:  Chemother Res Pract       Date:  2012-02-12

7.  Downregulation of miR-432 activates Wnt/β-catenin signaling and promotes human hepatocellular carcinoma proliferation.

Authors:  Nan Jiang; Wen-Jie Chen; Jian-Wen Zhang; Chi Xu; Xian-Cheng Zeng; Tong Zhang; Yang Li; Guo-Ying Wang
Journal:  Oncotarget       Date:  2015-04-10

8.  Pygopus-2 promotes invasion and metastasis of hepatic carcinoma cell by decreasing E-cadherin expression.

Authors:  Sheng Zhang; Jie Li; Pingguo Liu; Jianfeng Xu; Wenxiu Zhao; Chengrong Xie; Zhenyu Yin; Xiaomin Wang
Journal:  Oncotarget       Date:  2015-05-10

9.  Pygo2 functions as a prognostic factor for glioma due to its up-regulation of H3K4me3 and promotion of MLL1/MLL2 complex recruitment.

Authors:  Cefan Zhou; Yi Zhang; Jun Dai; Mengzhou Zhou; Miao Liu; Yefu Wang; Xing-Zhen Chen; Jingfeng Tang
Journal:  Sci Rep       Date:  2016-02-23       Impact factor: 4.379

Review 10.  Radioresistance of Brain Tumors.

Authors:  Kevin Kelley; Jonathan Knisely; Marc Symons; Rosamaria Ruggieri
Journal:  Cancers (Basel)       Date:  2016-03-30       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.